Thompson A J, Kermode A G, MacManus D G, Kendall B E, Kingsley D P, Moseley I F, McDonald W I
Multiple Sclerosis NMR Research Group, Institute of Neurology, London.
BMJ. 1990 Mar 10;300(6725):631-4. doi: 10.1136/bmj.300.6725.631.
To compare the abnormalities shown by magnetic resonance imaging of the brain in three clinically distinct groups of patients with multiple sclerosis, and to correlate the extent of abnormality with the degree of clinical disability in the three groups.
All patients underwent magnetic resonance imaging and full neurological examination, and their disability was scored according to the expanded Kurtzke disability state scale.
National Hospital for Nervous Diseases (Multiple Sclerosis NMR Research Group).
Three groups of patients with confirmed multiple sclerosis were studied: 12 patients with minimal disability despite a long (greater than 10 years) duration of illness (benign multiple sclerosis), 16 who had developed progressive disability after a relapsing and remitting course (secondary progressive multiple sclerosis), and 13 who had had progressive disability from the onset of the disease (primary progressive multiple sclerosis).
Number and size of lesions in 17 anatomically defined sites; total lesion load, estimated with an arbitrary scoring system weighted for the size of lesions; and disability score.
Magnetic resonance imaging showed that all 41 patients had abnormalities. These were extensive in the groups with secondary progressive and benign disease compared with the group with primary progressive disease. The lesions in the patients with secondary progressive disease were larger and more confluent than those in the two other groups (p = 0.007). Most lesions (85%) in the patients with primary progressive disease were under 5 mm in diameter; this percentage was higher than that in the two other groups (p = 0.032). Consequently the patients with primary progressive disease had the lowest mean lesion load (36.7); that in the patients with benign disease was 52.7 and that in the patients with secondary progressive disease 64.6 (p = 0.05). No correlation existed between disability and total lesion load. The distribution of brain lesions and of detectable lesions of the spinal cord, and the frequency of cortical atrophy, were similar in all groups.
No relation was found between the degree of clinical disability and the extent of abnormality shown by magnetic resonance imaging: patients with clinically benign disease often had extensive abnormalities and those with primary progressive disease had surprisingly few lesions. Though magnetic resonance imaging increases knowledge of the disease process in multiple sclerosis and is invaluable in diagnosis, it is not helpful in predicting disability in individual patients.
比较三组临床特征不同的多发性硬化患者的脑部磁共振成像表现,并将异常程度与三组患者的临床残疾程度进行关联分析。
所有患者均接受磁共振成像检查及全面的神经学检查,并根据扩展的Kurtzke残疾状态量表对其残疾情况进行评分。
国立神经病医院(多发性硬化核磁共振研究组)。
研究了三组确诊的多发性硬化患者:12例病程长(超过10年)但残疾程度轻微的患者(良性多发性硬化);16例在复发缓解病程后出现进行性残疾的患者(继发进展型多发性硬化);13例从疾病 onset 起就有进行性残疾的患者(原发进展型多发性硬化)。
17个解剖学定义部位的病灶数量和大小;采用根据病灶大小加权的任意评分系统估算的总病灶负荷;以及残疾评分。
磁共振成像显示,所有41例患者均有异常。与原发进展型疾病组相比,继发进展型和良性疾病组的异常更为广泛。继发进展型疾病患者的病灶比其他两组更大且更融合(p = 0.007)。原发进展型疾病患者的大多数病灶(85%)直径小于5毫米;这一比例高于其他两组(p = 0.032)。因此,原发进展型疾病患者的平均病灶负荷最低(36.7);良性疾病患者为52.7,继发进展型疾病患者为64.6(p = 0.05)。残疾与总病灶负荷之间无相关性。所有组的脑部病灶分布、脊髓可检测病灶情况以及皮质萎缩频率相似。
未发现临床残疾程度与磁共振成像显示的异常程度之间存在关联:临床症状良性的患者常有广泛异常,而原发进展型疾病患者的病灶出奇地少。尽管磁共振成像增加了对多发性硬化疾病进程的了解且在诊断中具有重要价值,但它对预测个体患者的残疾情况并无帮助。